




















A thesis submitted to Johns Hopkins University in conformity with the requirements for 



















Cancer cells in solid tumors often experience low oxygen and nutrition concentrations due to 
underdeveloped vasculature. Many studies have indicated that the altered oxygen and 
nutrition levels have profound effects on cancer metastasis, although the exact mechanism is 
still elusive. Improved understanding of the specific roles of oxygen and nutrition levels on 
metastasis could lead to the discovery of new therapeutic targets and better treatment 
methods.  
In this project, we aim to develop a microfluidic system to simulate the tumor 
microenvironment and tumor-vascular interface. We hope to use the system to study the 
effects of hypoxia and low nutrition concentrations on cancer local invasion and 
intravasation, two critical steps in early metastasis. Such in vitro models allow quantitative 
analysis of cell behaviors under precisely controlled cellular environment, which could 
generate valuable information for the study of specific microenvironmental factors. 
The design of the microfluidic device includes two main compartments: a cancer 
compartment connected with an endothelial channel, which mimics a blood vessel. In the 
cancer compartment, cancer cells were encapsulated in collagen hydrogel, which provided a 
more physiological relevant environment for cell culture and migration. The main objective 
of the design was to independently control the chemical concentrations in the two 
compartments, in particular, the oxygen tension. To accomplish the goal, our design employs 
two separate flow circuits to supply cell culture media for the two compartments. In order to 
achieve a better control of the oxygen concentration, the device was made of oxygen 
impermeable poly (methyl methacrylate).  
 iii 
One device was built and tested. Oxygen reading in the two compartments and 
fluorescent dye diffusion test indicate that we could independently control the concentrations 
of oxygen and other soluble molecules in the two compartments. Cancer cell and endothelial 
seeding were attempted. Due to time constraints, co-culture experiments were not performed 
in this project. In summary, we successfully developed and tested a microfluidic system that 
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Despite the significant achievements made in cancer research, cancer is still one of the 
leading causes of death, and metastasis is primarily responsible for deaths resulting from 
cancer (1). Local invasion and intravasation are two critical steps in early metastasis, and it is 
widely acknowledged that the tumor microenvironment has profound effects on a cancer 
cell’s ability to invade its surroundings and cross the endothelial barrier. A better 
understanding of the interactions between cancer cells and the microenvironment is 
necessary for the development of effective treatments to combat metastasis.  
Because of its poor vasculature, the microenvironment in solid tumors is often 
characterized by low oxygen and nutrition concentrations, which have been shown to 
regulate pathways that are involved in metastasis (2-4). For example, hypoxia up-regulates 
the expression of HIF-1, which promotes cancer invasion through some of the downstream 
pathways including Notch and TGF-β (5). Passive diffusion and cell consumption also create 
various chemical gradients that promote cancer cell migration and invasion (6). However, the 
exact roles of the altered oxygen and nutrition concentrations and gradients in cancer 
invasion and intravasation are still unclear.  
Technologies that allow for direct observation of cancer cell behaviors under 
precisely controlled chemical concentrations and gradients would be helpful in generating 
new knowledge about how these critical environmental factors drive cancer invasion and 
intravasation. Microfluidic systems allow accurate control and easy manipulation of the cell 
culture environment. In addition, cell behaviors could be observed and recorded using time-
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lapse microscopy. To better understand the specific roles of various concentrations and 
gradients in cancer progression, there is a need for the development of better microfluidic 
systems for the study of cancer metastasis. 
 
1.2 Project Objective 
In this project, I aim to develop a microfluidic system that is suitable for the study of the 
effects of low oxygen and nutrition concentrations on cancer local invasion and intravasation. 
The device is a cancer - endothelial co-culture microfluidic device that simulates the tumor 
microenvironment and tumor-vascular interface, and it allows precise control of the chemical 
concentrations and gradients experienced by cancer cells independent of the endothelial cells. 
A key objective of the project involves controlling the oxygen concentration and gradient 
within the device. Although there are designs to control concentrations and gradients of 
soluble molecules, current designs are inefficient in controlling concentrations and difficult 
to operate. Besides oxygen, other soluble molecules could be studied using the device. In this 




The microfluidic device developed in this project allows for real-time imaging and 
quantification of cell behaviors under precisely controlled chemical concentrations and 
gradients. Such technology would be useful in understanding the effects of specific 
microenvironmental factors in promoting cancer metastasis. In addition, in vitro models are 
important for the parameterization and validation of computational models, an area that has 
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garnered increasing interest in biomedical research. In vitro models allow parameters to be 
measured under well-controlled conditions, and can generate necessary input parameters for 
computational models. In vitro models are also excellent platforms for experimentally 
validating simulations. The microfluidic device developed in this project has the potential to 
assist in the development of computational models, which would play a key role in the study 












Figure 1.  Design concept development. The device mimics the situation of cancer cells adjacent to a blood 
vessel, and we aim to independently control the oxygen and nutrition concentrations in the cancer compartment 







2. Design of the Microfluidic System 
 
2.1 Microfluidic Chip Design 
   2.1.1 Device Layout 
To simulate the process of cancer invasion and intravasation, the device consists of two main 
compartments, the endothelial channel and the cancer compartment, connected by two small 
gap channels (Figure 2 & 3). The cancer compartment and the gap channels are filled with 
ECM hydrogel, providing a more physiologically relevant environment for cancer cells. The 
endothelial channel is seeded with endothelial cells to mimic a blood vessel. To simulate 
intravasation, the model requires a continuous endothelial monolayer at the hydrogel – EC 
channel interface. The design allows direct observation of cancer cells migrating and 
crossing the endothelial barrier under different chemical concentrations and gradients across 
the two compartments. Both the EC channel and the gap channels have square cross sections. 









Figure 2.  Schematics showing the design of the microfluidic device. Red: cancer compartment and gap 
channels. Blue: EC channel. 
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Figure 3. The developed microfluidic device. A) Device and cap partially connected with the tubing. B) 
Channels filled with blue dye 
 
 
   2.1.2 Concentration Control 
The device would be used to test whether important characteristics in the tumor environment, 
such as a low oxygen concentration and gradient, could promote cancer invasion and 
intravasation. To fulfill the goal, we need to be able to vary the concentrations in the cancer 
compartment while maintaining a consistent environment in the EC channel in different 
experiments.  
To independently control and maintain the chemical concentrations in the two 
compartments, cell culture media is supplied by a circulating system powered by a peristaltic 
pump. Each compartment has its own circuit, and can be filled with media of different 
compositions, such as varying glucose concentrations. With different concentrations in the 
cancer compartment and EC channel, a concentration gradient can be generated across the 
gap channel, mimicking the gradient commonly found in solid tumors.  
One challenge in this design involves controlling the device’s oxygen concentration. 
Microfluidic devices are generally made of polydimethylsiloxane (PDMS), which is highly 
A B 
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oxygen permeable. As a result, it is very difficult to independently control oxygen 
concentrations in the cancer compartment without interfering with the EC channel. Current 
designs utilize additional gas channels placed at different locations to generate oxygen 
gradients across the device. Such methods are inefficient, and the complexity of the design 
makes the device difficult to use, resulting in limited experimental usage (7). Using oxygen 
impermeable materials instead of PDMS would allow better control over oxygen 
concentrations in individual compartments. Hypoxia could be achieved by deoxygenating the 
media in an external media reservoir before flowing media into the device.  
 
   2.1.3 Flow System Design 
The flow system consists of two independent flow circuits powered by one peristaltic pump 
(Figure 4 & 5). There are two kinds of tubing. Because of the need to maintain low oxygen 
concentration in the cancer compartment, the flow circuit uses oxygen impermeable PTFE 
tubing (Cole-Parmer Instrument, Vernon Hills, Il). The endothelial channel circuit uses softer 
oxygen permeable tubing.  
Each flow circuit has its own media reservoir. Cancer media is directly deoxygenated 
inside the media reservoir, which is made of oxygen impermeable PMMA. To deoxygenate 
the media, gas containing 1% oxygen, 5% carbon dioxide 74% nitrogen was bubbled through 
the media in the reservoir. As the device and tubing for the tumor circulation system are in 
theory oxygen impermeable, the media remains deoxygenated when it reaches the cancer 
compartment. Oxygen concentration could then be modified by flowing gas with different 
oxygen concentrations. The design allows for easy and reliable control of the oxygen 












Figure 4.  Schematic depiction of the flow system. The system includes two separate flow systems for each 










    
 
 
Figure 5.  Complete flow system setup  
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   2.1.4 COMSOL Simulation 
To evaluate whether we could generate desired oxygen concentration profiles with the 
designed microfluidic system, steady state oxygen concentrations in the device were 
simulated using finite element analysis software COMSOL Multiphysics 5.1 (COMSOL, 
MA, USA). In addition, concentration profiles of another important soluble molecule, 
glucose, are simulated.  
The simulations were based on COMSOL transport of diluted species. All transport 
parameters, such as oxygen diffusion coefficients in collagen, were obtained from the 
literature (8-11). The cancer cell line we used for the project was KrasG12D/+, Ink4a/Arf fl/fl 
(KIA) mouse sarcoma cells, and the endothelial cell line was Human Umbilical Vein 
Endothelial Cells. The HUVEC glucose and oxygen uptake rates were obtained from Abaci 
et al and Guzzardi et al respectively. Since the oxygen and glucose concentrations in the EC 
channel are much higher than the Michaelis-Menten constant, we assumed the consumption 
rate to be zero order. KIA cell oxygen and glucose consumption rates were not available, so 
we estimated the values from normal cells (12). Oxygen consumption rates were modeled 
using Michaelis-Menten kinetics, and glucose consumption is modeled as first order (13, 14). 
To test the affects of cancer consumption variation on the concentration profiles, I perform a 
sensitivity analysis by perturbing cell consumption rates and diffusion coefficients. 
 The KIA cell density in the cancer compartment was 1.5 × 106 cells / ml. In the 
simulation, it was assumed HUVECs were confluent on all sides of the EC channel, and that 
the cell density was 4.5 × 105 cells / cm2 (10). It should be noted that the model only requires 
a HUVEC monolayer at the gel interface, and that HUVECs do not have to cover all four 
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sides throughout the entire channel. Our simulation tested a situation of maximum oxygen 
and glucose consumption in the EC channel. 
 
Parameter Value Reference 
Oxygen diffusion coefficient in media 3.35 × 10-5 cm2 / sec 10 
Oxygen diffusion coefficient in collagen 1.7 × 10-6  cm2 / sec 8 
Desired oxygen level in EC channel 0.22  mmol / L N/A 
Desired oxygen level in the cancer compartment 0.1 mmol / L N/A 
HUVEC oxygen consumption rate per cell 10-17 mol/sec 10 
Cancer O2 consumption baseline Vmax 2.5 × 10
-18 mol / sec 13 
Cancer O2 consumption baseline Km 10
-6 mol / L 13 
Glucose diffusion coefficient in collagen 1.3 × 10-6 cm2 / sec 9 
Glucose diffusion coefficient in media 5.67 × 10-6 cm2 / sec 11 
Desired glucose concentration in EC channel 1000 mg / L N/A 
Desired glucose concentration in the cancer compartment 100 mg / L N/A 
HUVEC glucose consumption rate per cell 3.47 × 10-14 g/sec 11 




We assumed that the flow system could effectively maintain the chemical 
concentrations in the media above the cancer compartment, and we set a constant 
concentration boundary on the top surface of the hydrogel in the cancer compartment. We 
assumed that there was no flow in the gap channel, and molecular transport is solely through 
diffusion. The flow rate in all the simulations was set to be 5 ml / hr. 
 Percent oxygen entering the EC channel was 21% and the glucose concentration was 
1000 mg/L respectively, which is the concentration in common endothelial cell media. In the 
cancer compartment, inflow media with 1% oxygen, 21% oxygen, 100mg/L glucose and 
1000mg/L glucose were simulated. 
 








    
 
 













Figure 6.  Oxygen and glucose concentration simulations results. Based on the simulation, the flow system 
design could effectively control the concentrations in the cancer compartment. Under hypoxic and low glucose 

















Figure 7. 3D simulation results of the oxygen concentration profiles. A) Hypoxic experiment setting. B) 
























































Figure 8. 3D simulation results of the glucose concentration profiles. A) Low glucose concentration experiment 



































Results from the simulations are shown in figure 6 - 8. As expected, under low 
glucose and hypoxic conditions, the concentrations in the gap channel decrease linearly, and 
the concentrations in the cancer compartment is very close to the concentrations we aim to 
achieve. The simulation results indicate that with two independent flow circuits, we could 
control the chemical concentrations in the cancer compartment without interfering with the 
EC channel and generate the desired gradients.  
Diffusion coefficients of the hydrogel could vary from the literature value, and 
oxygen and glucose consumption rates of KIA cancer cells are not available. To test the 
robustness of the assumed values for these parameters, I performed a sensitivity analysis on 
the oxygen and glucose diffusion coefficients in collagen, and on cancer oxygen and glucose 
consumption rates. The analysis involves comparing the concentration profile along the gap 
channel by varying one parameter at a time. Results are shown in figure 9 and 10. Modifying 
oxygen and glucose diffusion coefficients has a very small effect on the concentration 
profiles with respect to the control. Under low glucose and hypoxic conditions, a tenfold 
increase or decrease in these values still produces concentrations within the hypoxic and low 
glucose range in the cancer compartment. Changing the oxygen consumption rate by 50% 
does not result in large differences. Since cancer cells are known to have a high glucose 
consumption rate, we increased the consumption rate by ten times. This caused a small 
decrease in the concentration in the cancer compartment. Decreasing glucose consumption 













Figure 9.  Diffusion coefficient sensitivity analysis results: A) Oxygen concentration profiles along the gap channel 
with 10 fold perturbation in oxygen diffusion coefficients. B) Glucose concentration profiles along the gap channel with 10 











Figure 10.  Cancer consumption rate sensitivity analysis results: A) Oxygen concentration profiles along the gap 
channel with 50% perturbation in oxygen consumption rate. B) Glucose concentration profiles along the gap channel with 






   2.1.5 Device Material 
There are many oxygen impermeable materials that are available, such as poly (methyl 
methacrylate) (PMMA) and poly carbonate. PMMA was chosen to be the material for the 
device because of its mechanical strength and resistance to scratching. In addition, PMMA is 
transparent, allowing for easier observation.  
The top opening of the device is sealed with a PMMA cap secured by four screws at 
the four corners. Tubings are connected to the device using O-ring boss seals.  
 
   2.1.6 Device Fabrication 
The CAD model of the microfluidic device was designed using Autodesk Inventor 
(Autodesk, San Rafeal, CA, USA). PMMA blocks and O-rings were purchased from 
McMaster Carr, Santa Fe Springs, CA. The device was built in the Wyman machine shop at 










3. Microfluidic System Operation 
 
3.1 Cell Line and Cell Culture: 
Human Umbilical Vein Endothelial Cells (HUVEC) were cultured in endothelial growth 
medium (PromoCell, Heidelberg, Germany). HUVECs were passaged every 3 to 5 days 
using 0.05% trypsin. HUVECs used in experiments were either passage 4 or passage 5. 
KrasG12D/+, Ink4a/Arf fl/fl (KIA) mouse sarcoma cells were cultured in Dulbecco's 
Modified Eagle Medium (DMEM) with 10% FBS and 1% penicillin. KIA cells were 






Figure 11.  Device operation flow chart  
 
 
3.2 Device Assembly Using Wax Bonding 
 
   3.2.1 Bonding Procedure 
Currently, there are very few bonding methods available to bond PMMA and glass, and most 
of them require special equipment. In addition, the price of constructing our PMMA device is 
very high. In order for the device to be economically practical for laboratory research, the 
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bonding needs to be reversible, so that the device could be reused. Gong et al. reported using 












Figure 12.  3D drawing showing device assembly and tube connection. The glass slide was bonded with the 
device using wax and the tubings are secured with O-ring boss seals. 
 
 
Following the ideas reported by Gong et al, we developed the following protocol. Before 
assembly, the bottom surface of the device was cleaned with ethanol and small particles on 
the surface were removed using Scotch tape. Wax was melted at 80C. The bottom surface of 
the device was immersed in wax and attached to a glass cover slide. At this point, all 
channels were clogged with wax, which would need to be removed before the device could 
be used. To clean the wax, the device was first clamped tightly by a special metal scaffold in 
order to protect the wax layer between the device and glass (Figure 13A). The device was 
then placed in an 80 C hot water bath, and wax inside the channels was removed through 
washing with soap. The device was then allowed to cool down slowly. Afterwards, soap 
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water remaining the device was cleared with DI water and ethanol. Bright-field image of the 
channel after removal of wax is shown in figure 13B. The bonding could be easily reversed 












Figure 13. Wax Bonding. A) Device clamped by the metal scaffold before removing wax in the hot water 




   3.2.2 Bond Strength Testing 
The bond strength between the glass and the PMMA device was assessed using burst 
pressure test. The top of the device was sealed with a piece of glass slide using vacuum 
grease. One side of the cancer media channel was attached to pressurized gas source and the 
other side was sealed. Gas pressure was steadily increased to determine the burst pressure the 
device could withstand. In the three trials performed, average burst pressure was 0.063 mPa, 
and the standard deviation was 0.011 (Figure 14). Our bonding strength is comparable to that 
of other reversible bonding techniques, such as magnetic clamping (16, 17). In general, 
A B 
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reversible bonding is much weaker than irreversible bonding techniques such as PDMS 
plasma bonding (18). The bonding strength provided by wax is sufficient for the purpose of 
this project. Only one device was created, and it was still functioning by the end of the 
project, demonstrating the reversibility of this bonding method. PMMA has many advantages 
over PDMS. Besides its low oxygen permeability, PMMA additionally benefits from lower 
vapor permeability. Its rigidity and machinability also allow for more complex 3D structures. 
The lack of easy bonding techniques is one of the hurdles that prevent people from using 
PMMA for microfluidic fabrication. With wax bonding, PMMA would be able to play a 














   Figure 14.  Comparison of bond strength.  Our wax bonding strength is similar to other reversible bonding 
methods. Although it is lower than permanent bonding methods, such as PMMA thermal bonding, the strength 
is sufficient for the purpose of this project. 
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3.3 System Setup and Sterilization 
Reservoirs, tubing and the pump are first connected and assembled in a cell culture hood and 
sterilized by flowing 100% ethanol through the system for 5 minutes. Ethanol is then 
aspirated and any remaining ethanol is allowed to evaporate in a hood for at least 3 hours. 
Complete experiment procedure is shown in figure 11, and tubing attachment on the device is 
shown in figure 12. 
 
3.3 Flow Rate 
Media flow rate is one of the important parameters that need to be determined, and there are 
many factors that must to be considered when determining the flow rate of the system.  
First of all, the flow rate should be sufficient to provide enough oxygen and nutrition 
to the cells. Minimum flow rate required to support HUVEC cells inside the EC channel was 
calculated based on simple mass balance. Qmin = R * n / ΔC, where n is the number of cells 
and ΔC is the concentration difference between the inlet and outlet. Ideally, the oxygen 
concentration difference between the inlet and outlet should be less than 5 mmol / L, and the 
glucose concentration difference should be less than 50 mg/L. The calculated flow rate based 
on oxygen consumption is 0.5 ml / hr, and the calculated flow rate based on glucose 
consumption is 0.16 ml / hr.  
When designing the microfluidic system, we assumed the system to be completely 
oxygen impermeable. However, there will always be small oxygen exchanges between the 
system and the surroundings, such as leaks at the tube connections. As a result, the system 
would require the flow rate to be above a minimum value in order to counter oxygen 
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exchange with the external environment and maintain a low oxygen level in the cancer 
compartment.  
Another factor that needs to be considered is the pressure imbalance between the EC 
channel and the cancer compartment, which will result in liquid flow between the two 
compartments through the gap channels. The flow generated by peristaltic pumps is pulsed. 
Since both flow circuits are powered by a single peristaltic pump, a high flow rate would 
result in a large inter-compartmental flow, affecting concentration profiles and cell 
behaviors.  
Considering all the factors mentioned above, the final flow rate is set to be 5 ml per 
hour. 
 
3.4 Hydrogel Injection and Cancer Cell Seeding 
In order to provide a more physiological relevant environment for cancer cell culture and 
migration, the cancer compartment and the gap channels were filled with type I collagen. To 
improve the attachment of collagen to PMMA, the device was coated with 1 mg/L poly D 
lysine (PDL) (Sigma-Aldrich, St Louis, MO) at 37 C for 10 hours, and further dried at 37 C 
for another 12 hours. The device was then washed three times using DI water. Rat Tail Type 
I Collagen (Corning, Midland, MI, USA) was used to form the hydrogel scaffold. Collagen 
was made following a protocol established by Nguyen-Ngoc et al (19). After mixing, 5 μl of 
collagen without cells was injected directly from the cancer well into the gap channel. 8 μl of 
collagen with cancer cells was then introduced into the cancer compartment, and was mixed 
with previously injected collagen inside the cancer compartment (Figure 15). The device 










Figure 15.  Cancer compartment hydrogel injection. A) Collagen in the gap channels after injection. B) Day 1 




3.5 Endothelial Cell Seeding 
After cancer cell seeding, HUVEC cells were introduced into the EC channel to generate the 
tumor-vascular interface. The most successful experiment procedure is reported here, and 
further evaluation of the seeding protocol is described in section 4.3. 
After seeding KIA cells in the cancer compartment, endothelial cells were introduced 
into the EC channel. Because the device was made of oxygen impermeable PMMA, cells 
could not obtain oxygen diffused from the external environment, and would need to rely on 
the limited amount of oxygen present in the cell culture media. As a result, a flow needed to 
be generated immediately to provide sufficient oxygen for the endothelial cells. In order to 
minimize the effects on the initial cell attachment, we used a syringe pump to generate a flow 
going from the EC channel to the cancer compartment. This initial inter-compartmental flow 
served two purposes: 1) providing oxygen to the endothelial cells, 2) encouraging endothelial 
A B 
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cell attachment at the gel interface. After 1.5 hour, the inter-compartmental flow was stopped 
and replaced by the circulating flow powered by the peristaltic pump. 
 
4. Device Characterization 
 
4.1 Oxygen Reading 
 
   4.1.1 Experiment Procedure 
To experimentally test the oxygen concentrations inside the device, oxygen tensions in the 
two compartments were monitored using fluorescent oxygen sensors (OXY-4 mini, PreSens 
GmbH, Regensburg, Germany). The sensors were placed inside the device using silicon 
vacuum grease (Dow Corning, Midland, MI). One sensor was placed in the cancer well, and 
the other sensor was placed at the outlet of the EC channel (Figure 16). The experiments 
were conducted under a flow rate of 5 ml/hr for a period of 24 hours.  
 
 






Figure 16. Oxygen sensor placements in the device. The figure shows the top view of the device and the red 
dots indicate the locations of the sensors. 
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   4.1.2 Acellular Oxygen Reading 
To test whether the design could achieve low oxygen level in the cancer compartment while 
maintaining normoxia in the EC channel, oxygen concentrations in the two compartments 
were monitored for 24 hours. To test the effectiveness of the flow system in controlling 
oxygen level, this experiment was conducted without cells in the device. Due to time 

















Figure 17. Acellular oxygen reading. The experiment was repeated twice; mean and standard deviation were 
calculated. Overall, the performance was stable, and the cancer compartment reached below 5% oxygen very 






The oxygen concentration in the cancer compartment quickly decreased to around four 
percent, while the concentration in the EC channel stabilized at around 20% (Figure 17). The 
steady state oxygen concentrations in the cancer compartment were higher than the 
prediction by the COMSOL simulation, which might be caused by small leaks in the system. 
This experiment would need to be repeated more times in order to further validating the 
reliability of the flow system design. 
 
   4.1.3 Oxygen Reading with Cancer Cells 
Cell consumption might affect oxygen control inside the device. With cancer cells 
encapsulated inside collagen, oxygen concentrations inside the cancer compartment would 
decrease. To test the effects of cancer cells on oxygen concentrations, oxygen tension was 












Figure 18.  Oxygen reading with cancer cells cultured in the cancer compartment. A) Oxygen reading under 
hypoxic experiment setting. B) Oxygen reading under normoxic experiment setting. 
A B 
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Under hypoxia experiment settings, oxygen concentration in the cancer compartment 
decreased slowly over the first two days, and reached steady state at around 2% oxygen 
(Figure 18A). Under normoxic experimental settings, oxygen concentration decreased 
gradually over three days to around 15%, which is still within the normoxic range (Figure 
18B). The results show that the flow system could effectively control the oxygen tension 




4.2 Experimental Characterization of Concentration Gradient 
 
   4.2.1 Experiment Procedure 
To experimentally test the concentration gradient formation between the EC channel and the 
cancer compartment, we introduced a small fluorescent molecule, Lucifer yellow, to the EC 
channel. The concentrations were measured based on fluorescent intensity. The experiment 
was performed using a Nikon A1-Rsi confocal microscope with 10X magnification. The 
wavelength is 405 nm and the exposure time is 400 ms. Images were taken every minute for 
three hours. For simplicity, we used a basic gravity driven flow system with a flow rate of 
approximately 3 ml/hr. 1 mM Lucifer yellow was added to the EC reservoir after the flow 
was established and stabilized. Flow rate was verified at the end of the experiment by 
measuring the liquid volume in the reservoirs. Images were analyzed using imageJ. Relative 
concentration plots were graphed in Matlab. 
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   4.2.2 Results 
After the introduction of Lucifer yellow, the intensity gradient was observed across the gap 
channel and reached the steady state in approximately 15 min. The experimental 
measurements and the COMSOL simulation matched well, although one key difference was 
the shapes of the profiles across the gap channel. The simulation indicates that concentration 
profile should be linear. The curved shape in the experimental data might be caused by slow 
inter-compartmental flow going from the cancer compartment to the EC channel.  
 
    
    
Figure 19:  Fluorescent images of Lucifer yellow gradient across the gap channel. Images taken at 5 min, 











Figure 20.  Concentration profiles generated based on the fluorescent intensity. A) Concentration profiles at 5 







4.3 HUVEC Cell Seeding 
 
   4.3.1 Evaluation 
After seeding HUVEC cells in the EC channel, cell attachment and viability were observed 
using bright-field images and live/dead staining. Bright-field images were taken at 1.5 hours 
after seeding and day 1. Live and dead staining was performed on day 1 following the 
manufacturer’s instructions. Both bright-field image and fluorescent images were taken using 




   4.3.2 Results 
Several attempts have been made to seed HUVECs in the EC channel. Following the 
procedure reported in section 3.5, I provide results of one of the experiments. After 1.5 hours 
of inter-compartmental flow, cell attachment was observed on the bottom surface of the 
channel and at the gel interface (Figure 21A). We then switched to a circulating flow using 
the peristaltic pump. After one day of flow, cells attached to the bottom showed good 
morphology (Figure 21B), while most of the cells at the hydrogel interface had detached. 
Live and dead staining also showed good cell viability at the bottom of the channel (Figure 
22). There are very few dead cells as the cells with low viability are likely to be washed away 
under the flow. The cause of the detachment at the collagen interface was still elusive. The 
most likely explanation is the stress resulted from the inter-compartmental flow. Since the 
flow powered by peristaltic pumps is pulsed, cells attached on collagen constantly 
experienced oscillating flow passing through the gap channel. The stress resulted from the 




























Figure 21.  EC channel bright-field images.  A) 4X bright-field image of the HUVEC cells after 1.5 hour inter-
compartmental flow. B) 4X bright field image taken on day 1. C) 10X bright field image taken on day 1 at the 























Figure 22.  EC channel live and dead staining. A) 4X fluorescent image of the HUVEC cells on day 1. B) 10X 


















In this project, we developed a microfluidic system that could be used to study the effects of 
concentrations and gradients of soluble molecules in the tumor microenvironment on cancer 
cell invasion and intravasation. As indicated by the oxygen reading and Lucifer yellow 
diffusion test, the device allows effective control of different chemical concentrations, such 
as dissolved oxygen, experienced by the cancer cells, while leaving the endothelial cells 
unaffected. Cell seeding experiments indicate that the design of the system could support cell 
survival. Generating a continuous endothelial monolayer was shown to be difficult and 
would be an important topic to explore in the future.  
 
5.2 Flow System and Concentration Control 
One of the primary challenges of the project was the design of the flow system (Figure 4 & 
5). Using a peristaltic pump to drive the circulating flow is a simple design that also provides 
good control over the flow rate. The results of the oxygen reading showed that the design 
allowed independent control of different chemical concentrations, including dissolved gas in 
the two compartments (Figure 17 & 18). This enabled us to test how concentrations and 
gradients of different molecules in the cancer microenvironment could affect cancer cell 
behaviors while keeping the cell culture conditions in the EC channel throughout the 
experiments.  
A limitation of the design was that the impulse flow generated by the peristaltic pump 
resulted in inter-compartment flow through the gap channel. While the inter-compartmental 
flow had little effects on the chemical concentrations in the two compartments, it would 
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likely alter the gradients along the gap channel. The Lucifer yellow diffusion test was 
performed using gravity driven flow, and the results demonstrate that we could generate a 
stable gradient in the absence of significant inter-compartmental flow (Figure 19 & 20). The 
exact effect of inter-compartmental flow on the gradient would need to further tested, but it 
would certainly need to be minimized.  
In addition, the inter-compartmental flow could have serious negative effects on the 
cells cultured in the device. As discussed in section 5.4.2, it is highly likely that the stress 
resulting from inter-compartmental flow caused the endothelial cell detachment at the 
hydrogel interface.  
An alternative flow system design is gravity drive system. A gravity driven system 
generates smooth and stable flow, but still presents difficulties in balancing the pressure 
between the two compartments and preventing inter-compartmental flow. Besides, it is 
challenging to precisely control the flow rate using gravity driven flow. When assembling the 
gravity driven system for the Lucifer yellow gradient test, a significant amount of time was 
spent determining the correct reservoir placement to achieve pressure balance and generate 
the desired flow rate.  
 
5.3 HUVEC Seeding 
Developing the EC channel seeding protocol is an important part of the project. An early 
challenge was providing sufficient oxygen for the newly seeded cells without interfering with 
the initial attachment. Cell seeding in PDMS devices usually allows cells to attach statically 
for a couple hours, and the high oxygen permeability of PDMS allows cells to obtain oxygen 
diffused from the outer environment. Since our device was made out of oxygen impermeable 
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PMMA, oxygen would deplete quickly without media flow, and static attachment would not 
be feasible. To solve the problem, we created an inter-compartmental flow going from the 
EC channel to the cancer compartment. The flow not only provided the needed oxygen for 
cells, but also helped move cells onto the hydrogel interface to generate an endothelial 
monolayer. As shown in the figure 19, after 1.5 hours of inter-compartmental flow, there was 
a significant amount of cells attached. Compared to other trials that allowed a short duration 
for static attachment, inter-compartmental flow achieved the best cell attachment results. 
Another existing challenge was to maintain the continuous monolayer at the delicate and soft 
hydrogel interface. Many trials successfully generated an endothelial monolayer after inter-
compartmental flow, but cells at the interface detached on day 1 after a period of peristaltic 
flow. The exact reason for cell detachment is still unclear, but we hypothesized that it 
resulted from the stress caused by inter-compartmental flow. Cell morphology and live dead 
staining indicated good cell viability at the bottom surface of the channel (Figure 20 & 21), 
excluding the possibility that cell detachment was caused by cytotoxicity, insufficient 
oxygen, or inadequate nutrition supply. To find the actual reason, time-lapse experiments 
could provide valuable information about how the detachment really happened. If, for 
example, the detachment was caused by inter-compartmental flow, modifying channel design 
and improving flow system would be important steps necessary for solving the problems. 
 
5.4 Future Remarks 
There were several limitations on this project due to time constraints. Our endothelial cell 
seeding protocol would need to be further investigated. Based on the experimental results 
achieved in this project, a flow system that could generate smoother flow might provide 
better results. Furthermore, the underlying biological problems that motivated the 
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development of this microfluidic system were not explored. The design of the device allows 
live-time observations, and cell migration could be studied using 3D tracking under a 
fluorescent microscope. However, fitting the entire system onto the scope would still be 
difficult. Currently, the device only has two gap channels that connect the cancer 
compartment with the EC channel, limiting the number of cell that migrate and interact with 
the endothelial cells. One solution is to add more gap channels to the device. Since passive 
diffusion is a slow process, additional gap channels will not damage independent 
concentration control in the two compartments, given that there is no significant inter-
compartmental flow across the gap channels. Another solution is to connect multiple devices 
in parallel to increase the sample size obtainable in one experiment. Only after addressing 
these technical challenges could this device be useful for observing how altered 
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